We are continuing to work with and deliver for our partners during the COVID-19 pandemic. Read our full response for more details.

Kris Wadrop

General Manager Biotechnology & Step-Out Business Units

Kris is the General Manager of the Biotechnology and Step-Out Business Units.

As GM Kris will work with Arun, CPI’s Strategy Director, in developing the operating models and mobilisation of CPI’s “Step Out” strategies, progressing to taking full accountability for the delivery phase of the new Business Units as they are created.

Kris also has full operating accountability for the Biotechnology Business Unit which is integral in the execution of the UK’s Bioeconomy strategy from its base at the Wilton Centre, Redcar.

He originally joined CPI in 2015 as Technical Programme Director developing the Biotechnology strategy for CPI and securing long term partnerships with customers such as Calysta LLC; Kris became the Director of Biotechnology in 2016 from which time he has helped steer the National Strategy to a sustainable and prosperous future for UK manufacturing. Kris is a member of the Industrial Biotechnology Leadership Forum (IBLF); the IBLF is the collaboration between UK Government and Industry to drive the UK’s Bioeconomy.

Prior to joining CPI Kris was a customer through an SME he founded; he used this experience to drive a culture of Continuous Improvement within the Biotechnology business unit. The latter half of Kris’ career has been in SME’s driving fundraising in combination with technology and project development; the first half was in ICI. Whilst at ICI Kris was held both operational management and technology management roles across a range of sites stretching from Indonesia to the USA making the essential ingredients for everyday products used in detergents, lubricants and clothing.

Kris’ entrepreneurial spirit and drive for results enables him to see the big picture whilst designing a tactical plan to deliver near term results; Kris’ ability to join the dots and take existing technology into new applications and markets often allows step changes in cost-effectiveness or revenue growth.

Kris Wadrop